Expression of hyaluronidase bytumor cells induces angiogenesis in vivo
GM501 Hyaluronidase EN GYNEMED
Transcript of GM501 Hyaluronidase EN GYNEMED
Material included in the package: • 1x10mlGM501Hyaluronidase• 5x1mlGM501Hyaluronidase
Material not included in the package:• Incubator(at37°C,noCO2)
• Petridishes
• Pipette suitable for denudation ofoocytes
• LAF-bench(ISO5environment)
• MineralOil(e.g.GM501MineralOil)
• Washingmedium(e.g.GM501Wash)
Product code:• 4HY0010 (1 x 10 ml)• 4HY0001-5 (5 x 1 ml)
Composition:• 80 IU/ml pharmaceutical grade
hyaluronidase from bovine originsolvedinHEPES-bufferedmedium,containing 4.00 g/liter human se-rumalbumin.
Intended use/Intended users:• GM501 Hyaluronidase is a ready-
to-use solution designed to fa-cilitate the mechanical removal ofcumulus cells. Hyaluronidase di-geststheextracellularmatrixinthecumulus-oocyte complex consist-ingofhyaluronicacid.
• TheintendedusersareIVFprofes-sionals (labtechnicians,embryolo-gistsormedicaldoctors).
pH(at37°C)7.30-7.60
Osmolality(mOsm/kg)270-290
Instructions for use:• GM501HyaluronidasecontainsHEPES;noCO2 incuba-
tion is required, justwarm itup to37°C (incubation inaCO2incubatorwilllowerthepHbelow7).
• Dependingonthedishes,100µl(micodrops)or400-600µl (center-/4-well) of GM501 Hyaluronidase should beusedfordenudation.
• Additionallyprepare3-5drops(100µl)ofwashingmedium(e.g.GM501Wash)foroocytewashing.
• The dishes should be covered with Mineral Oil (e.g.GM501MineralOil).
• PlacetheoocyteintheHyaluronidase(uptomax.5oo-cytes)forabout30seconds.
• Usingafinepipette,transferthepartiallydenudedoocytestothefirstwashingdrop.
• Removethecoronabyrepeatedlypipettingtheoocytes.
• Usetheotherdropstofurtherwashthedenudedoocyte.
Product specifications and quality control:• Allrawmaterialsareofhighestavailablepurity(European
Pharmacopoeiaand/orUSPstandard),ifapplicable.
• Acertificateofanalysis isavailable foreachbatchuponrequestfromourwebsitewithrespectivelotnumber.
• The MSDS for GM501 Hyaluronidase is available uponrequestandcanalsobedownloadedfromourwebsite.
• GM501 Hyaluronidase is manufactured and tested ac-cordingtothefollowingspecifications:
Precautions and warnings:• Standard measures to prevent infections resulting from
theuseofmedicinalproductspreparedfromhumanbloodorplasmaincludeselectionofdonors,screeningofindi-vidual donations and plasmapools for specificmarkersof infection and the inclusionof effectivemanufacturingstepsfortheinactivation/removalofviruses.Despitethis,whenmedicinalproductspreparedfromhumanbloodorplasma are administered, the possibility of transmittinginfectiveagentscannottotallybeexcluded.Thisalsoap-plies to unknown or emerging viruses and other patho-gens.Therearenoreportsofprovenvirustransmissionswithalbumin,manufacturedtoEuropeanPharmacopoeiaspecificationsbyestablishedprocesses.
• HandleallspecimensasifcapableoftransmittingHIVorhepatitis.Alwayswearprotectiveclothingwhenhandlingspecimens.
• Productdoesnotcontainanyantibiotics.Alwaysworkun-derstricthygienicconditions(e.g.LAF-bench,ISOClass5)toavoidpossiblecontamination.
• Onlyfortheintendeduse.
Pre-use checks:• Donotusetheproductifbottle,sealofthecontaineror
package isopenedordefectwhen theproduct isdeliv-ered.
• Donotusetheproductifitbecomesdiscoloured,cloudyorshowsanyevidenceofmicrobialcontamination.
GM501 Hyaluronidase GYNEMEDEN
Sterilitysterile-SAL10-3(SterilityAssuranceLevel)
Endotoxins(EU/ml)<1.00
MEA ≥ 80(1-cellassay,blastocystsafter96hin%)
For technical support:
GYNEMEDMedizinprodukteGmbH&Co.KG, LübeckerStraße9,23738Lensahn-Germany Phone:+49(0)436390329-0- Fax:+49(0)436390329-19 Email:[email protected] http: //www.gynemed.de
Gebrauchsanweisung:GM501_Hyaluronidase:Gebrauchsanweisung_GM501_Hyaluronidase_EN_Rev03_00.inddStand:2017-03-13
Bovine sourced Hyaluronidase:• ThePharmaceutical grade hyaluronidase used in this product is sourced from
bovinetestis.Itiscertifiednottocontainanyneuronaltissue(CertificateofSuit-ability/CEP).
• Hyaluronidaseissourcedfromanimalsdetermined„fitforhumanconsumption“andoriginatingfromcountrieswith„negligibleBSErisk“(ResolutionNo.18„Rec-ognitionoftheBovineSpongiformEncephalopathyRiskStatusofMemberCoun-tries(2014)“,adoptedbytheOIE).
• Accordingtothe„WHOguidelineonTransmissibleSpongiformEncephalopathiesinRelationtoBiologicalandPharmaceuticalProduct“,andaccordingtoECdirec-tive2004/C24/03„Noteforguidanceonminimisingtheriskoftransmittinganimalspongiformencephalopathyagentsviahumanandveterinarymedicinalproducts(EMA/410/01) adopted by the Committee for Proprietary Medicinal Products(CPMP)andbytheCommitteeforProprietaryMedicinalProducts(CVMP)“,testismaterialfrombovinesourceisclassifiedasa„CategoryC:Tissueswithnode-tectedinfectivity“product.
Storage instructions and stability:• Theshelflifeis12monthsfromtimeofmanufacture.
• Storebetween2-8°C.
• Donotfreezebeforeuse.
• Keepawayfrom(sun)light.
• Theproductcanbeusedsafelyupto7daysafteropening,whensterilecondi-tionsaremaintainedandtheproductsarestoredat2-8°C.
• Donotuseafterexpirydate.
• Stableaftertransport(max.5days)atelevatedtemperature(≤37°C)
Consultinstructionsforuse
Temperaturelimitation
Lotnumber
Useby
Cataloguenumber
Donotuseifpackageisdamaged
Sterilizedusingasepticprocessingtechniques(filtration)
Keepawayfrom(sun)light
GM501 Hyaluronidase GYNEMEDEN
0344